Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2.

MLA

Lehtokari, Vilma-Lotta, et al. “Cap Disease Caused by Heterozygous Deletion of the Beta-Tropomyosin Gene TPM2.” Neuromuscular Disorders : NMD, vol. 17, no. 6, June 2007, pp. 433–42. EBSCOhost, https://doi.org/10.1016/j.nmd.2007.02.015.

APA

Lehtokari, V.-L., Ceuterick-de Groote, C., de Jonghe, P., Marttila, M., Laing, N. G., Pelin, K., & Wallgren-Pettersson, C. (2007). Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2. Neuromuscular Disorders : NMD, 17(6), 433–442. https://doi.org/10.1016/j.nmd.2007.02.015

Chicago

Lehtokari, Vilma-Lotta, Chantal Ceuterick-de Groote, Peter de Jonghe, Minttu Marttila, Nigel G Laing, Katarina Pelin, and Carina Wallgren-Pettersson. 2007. “Cap Disease Caused by Heterozygous Deletion of the Beta-Tropomyosin Gene TPM2.” Neuromuscular Disorders : NMD 17 (6): 433–42. doi:10.1016/j.nmd.2007.02.015.